BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON(BRNS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BRNS BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON

总统日休市 02-13 16:00:00 EST

0.6290

+0.0034

+0.54%

盘后0.6290

+0.00000.00%

16:10 EST

最高0.6870	最低0.5900	成交量14.26万
今开0.6421	昨收0.6256	日振幅15.51%
总市值2,568万	流通市值2,244万	总股本4,083万
成交额9.20万	换手率0.40%	流通股本3,568万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BRNS","market":"US","secType":"STK","nameCN":"BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON","latestPrice":0.629,"timestamp":1771016400000,"preClose":0.6256,"halted":0,"volume":142634,"hourTrading":{"tag":"盘后","latestPrice":0.629,"preClose":0.629,"latestTime":"16:10 EST","volume":1,"amount":0.629,"timestamp":1771017004703,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.005434782608695585,"floatShares":35677165,"shares":40830353,"eps":-1.880153,"marketStatus":"总统日休市","change":0.0034,"latestTime":"02-13 16:00:00 EST","open":0.642101,"high":0.687,"low":0.59,"amount":91991.912407,"amplitude":0.155051,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.880153,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1771318800000},"marketStatusCode":7,"adr":0,"adrRate":1,"listingDate":1619755200000,"exchange":"NASDAQ","adjPreClose":0.6256,"postHourTrading":{"tag":"盘后","latestPrice":0.629,"preClose":0.629,"latestTime":"16:10 EST","volume":1,"amount":0.629,"timestamp":1771017004703,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.377431457772582},"requestUrl":"/m/hq/s/BRNS","defaultTab":"news","newsList":[{"id":"2600170240","title":"Barinthus Biotherapeutics Plc盘中异动 股价大涨5.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2600170240","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600170240?lang=zh_cn&edition=full","pubTime":"2026-01-01 03:24","pubTimestamp":1767209059,"startTime":"0","endTime":"0","summary":"北京时间2026年01月01日03时24分，Barinthus Biotherapeutics Plc股票出现异动，股价快速拉升5.64%。Barinthus Biotherapeutics Plc股票所在的生物技术行业中，整体涨幅为0.23%。Barinthus Biotherapeutics Plc公司简介：Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260101032420a6e69a7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260101032420a6e69a7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BRNS","BK4539"],"gpt_icon":0},{"id":"2570073134","title":"Barinthus Biotherapeutics Plc盘中异动 早盘急速下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2570073134","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570073134?lang=zh_cn&edition=full","pubTime":"2025-09-25 22:43","pubTimestamp":1758811396,"startTime":"0","endTime":"0","summary":"北京时间2025年09月25日22时43分，Barinthus Biotherapeutics Plc股票出现波动，股价快速下挫5.00%。Barinthus Biotherapeutics Plc股票所在的生物技术行业中，整体跌幅为0.86%。其相关个股中，Scisparc Ltd.、Pepgen Inc.、Evaxion A/S涨幅较大，Scisparc Ltd.、Evaxion A/S、Pepgen Inc.较为活跃，换手率分别为4213.24%、1041.26%、255.24%，振幅较大的相关个股有Scisparc Ltd.、Pepgen Inc.、Leap Therapeutics, Inc.，振幅分别为91.12%、46.99%、28.47%。Barinthus Biotherapeutics Plc公司简介：Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509252243169544ea99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509252243169544ea99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BRNS","BK4139"],"gpt_icon":0},{"id":"2564339069","title":"Barinthus Biotherapeutics Plc盘中异动 股价大涨10.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2564339069","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564339069?lang=zh_cn&edition=full","pubTime":"2025-09-02 21:34","pubTimestamp":1756820045,"startTime":"0","endTime":"0","summary":"北京时间2025年09月02日21时34分，Barinthus Biotherapeutics Plc股票出现波动，股价急速拉升10.21%。Barinthus Biotherapeutics Plc股票所在的生物技术行业中，整体涨幅为0.75%。其相关个股中，Carisma Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Cytokinetics, Incorporated涨幅较大，Carisma Therapeutics, Inc.、Hoth Therapeutics, Inc.、Kairos Pharma, Ltd.较为活跃，换手率分别为400.90%、80.68%、32.18%，振幅较大的相关个股有Carisma Therapeutics, Inc.、Akari Therapeutics Plc、Mineralys Therapeutics, Inc.，振幅分别为23.49%、22.86%、18.15%。Barinthus Biotherapeutics Plc公司简介：Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250902213405a70bb773&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250902213405a70bb773&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","BRNS"],"gpt_icon":0},{"id":"2558694614","title":"Barinthus Biotherapeutics Plc8月11日成交额为12.81万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558694614","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558694614?lang=zh_cn&edition=full","pubTime":"2025-08-12 09:28","pubTimestamp":1754962104,"startTime":"0","endTime":"0","summary":"美东时间2025年8月11日，Barinthus Biotherapeutics Plc成交额为12.81万美元，成交额较昨日增加281.03%，当日成交量为10.92万股。Barinthus Biotherapeutics Plc于2025年8月11日跌14.93%，报1.14美元，该股过去5个交易日跌11.63%，年初至今跌5.79%，过去60日涨28.09%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-11|12.81万|281.03%|10.92万|#|2025-08-08|3.36万|-30.33%|2.51万|#|2025-08-07|4.82万|9.73%|3.55万|#|2025-08-06|4.40万|-62.36%|3.25万|#|2025-08-05|11.68万|92.77%|8.56万|Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812092834a6e0870e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812092834a6e0870e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","BRNS"],"gpt_icon":0},{"id":"2558665758","title":"Barinthus Biotherapeutics Plc盘中异动 早盘急速跳水5.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558665758","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558665758?lang=zh_cn&edition=full","pubTime":"2025-08-11 21:48","pubTimestamp":1754920115,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日21时48分，Barinthus Biotherapeutics Plc股票出现异动，股价快速跳水5.97%。Barinthus Biotherapeutics Plc股票所在的生物技术行业中，整体涨幅为0.25%。Barinthus Biotherapeutics Plc公司简介：Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811214836a6dfbf8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811214836a6dfbf8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BRNS","BK4539","BK4139"],"gpt_icon":0},{"id":"2558636503","title":"Barinthus Biotherapeutics Plc8月8日成交额为3.36万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558636503","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558636503?lang=zh_cn&edition=full","pubTime":"2025-08-09 09:28","pubTimestamp":1754702898,"startTime":"0","endTime":"0","summary":"美东时间2025年8月8日，Barinthus Biotherapeutics Plc成交额为3.36万美元，成交额较昨日减少30.33%，当日成交量为2.51万股。Barinthus Biotherapeutics Plc于2025年8月8日跌7.59%，报1.34美元，该股过去5个交易日跌4.29%，年初至今涨10.74%，过去60日涨47.25%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-08|3.36万|-30.33%|2.51万|#|2025-08-07|4.82万|9.73%|3.55万|#|2025-08-06|4.40万|-62.36%|3.25万|#|2025-08-05|11.68万|92.77%|8.56万|#|2025-08-04|6.06万|-1.01%|4.49万|Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809092826a47e1f7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809092826a47e1f7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BRNS","BK4539","BK4139"],"gpt_icon":0},{"id":"2557015515","title":"Barinthus Biotherapeutics Plc8月7日成交额为4.82万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557015515","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557015515?lang=zh_cn&edition=full","pubTime":"2025-08-08 09:28","pubTimestamp":1754616493,"startTime":"0","endTime":"0","summary":"美东时间2025年8月7日，Barinthus Biotherapeutics Plc成交额为4.82万美元，成交额较昨日增加9.73%，当日成交量为3.55万股。Barinthus Biotherapeutics Plc于2025年8月7日涨10.69%，报1.45美元，该股过去5个交易日跌2.03%，年初至今涨19.83%，过去60日涨55.91%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-07|4.82万|9.73%|3.55万|#|2025-08-06|4.40万|-62.36%|3.25万|#|2025-08-05|11.68万|92.77%|8.56万|#|2025-08-04|6.06万|-1.01%|4.49万|#|2025-08-01|6.12万|-82.28%|4.33万|Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808092821a47c016b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808092821a47c016b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","BRNS"],"gpt_icon":0},{"id":"2557581478","title":"Barinthus Biotherapeutics Plc8月6日成交额为4.40万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557581478","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557581478?lang=zh_cn&edition=full","pubTime":"2025-08-07 09:27","pubTimestamp":1754530034,"startTime":"0","endTime":"0","summary":"美东时间2025年8月6日，Barinthus Biotherapeutics Plc成交额为4.40万美元，成交额较昨日减少62.36%，当日成交量为3.25万股。Barinthus Biotherapeutics Plc于2025年8月6日跌5.07%，报1.31美元，该股过去5个交易日跌9.03%，年初至今涨8.26%，过去60日涨51.1%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-06|4.40万|-62.36%|3.25万|#|2025-08-05|11.68万|92.77%|8.56万|#|2025-08-04|6.06万|-1.01%|4.49万|#|2025-08-01|6.12万|-82.28%|4.33万|#|2025-07-31|34.55万|171.78%|23.60万|Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807092720a6d792aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807092720a6d792aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","BRNS"],"gpt_icon":0},{"id":"2557457603","title":"Barinthus Biotherapeutics Plc8月5日成交额为11.68万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557457603","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557457603?lang=zh_cn&edition=full","pubTime":"2025-08-06 09:26","pubTimestamp":1754443597,"startTime":"0","endTime":"0","summary":"美东时间2025年8月5日，Barinthus Biotherapeutics Plc成交额为11.68万美元，成交额较昨日增加92.77%，当日成交量为8.56万股。Barinthus Biotherapeutics Plc于2025年8月5日涨6.98%，报1.38美元，该股过去5个交易日跌9.8%，年初至今涨14.05%，过去60日涨53.33%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-05|11.68万|92.77%|8.56万|#|2025-08-04|6.06万|-1.01%|4.49万|#|2025-08-01|6.12万|-82.28%|4.33万|#|2025-07-31|34.55万|171.78%|23.60万|#|2025-07-30|12.71万|107.16%|8.97万|Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806092643a6d56fb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806092643a6d56fb1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","BRNS"],"gpt_icon":0},{"id":"2557277338","title":"Barinthus Biotherapeutics Plc盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557277338","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557277338?lang=zh_cn&edition=full","pubTime":"2025-08-04 23:56","pubTimestamp":1754322994,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日23时56分，Barinthus Biotherapeutics Plc股票出现异动，股价大幅下挫5.00%。Barinthus Biotherapeutics Plc股票所在的生物技术行业中，整体涨幅为1.05%。Barinthus Biotherapeutics Plc公司简介：Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804235634973334e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804235634973334e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","BRNS"],"gpt_icon":0},{"id":"2556670850","title":"Barinthus Biotherapeutics Plc7月31日成交额为34.55万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556670850","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556670850?lang=zh_cn&edition=full","pubTime":"2025-08-01 09:26","pubTimestamp":1754011584,"startTime":"0","endTime":"0","summary":"美东时间2025年7月31日，Barinthus Biotherapeutics Plc成交额为34.55万美元，成交额较昨日增加171.78%，当日成交量为23.60万股。Barinthus Biotherapeutics Plc于2025年7月31日涨2.78%，报1.48美元，该股过去5个交易日跌15.43%，年初至今涨22.31%，过去60日涨54.17%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-31|34.55万|171.78%|23.60万|#|2025-07-30|12.71万|107.16%|8.97万|#|2025-07-29|6.14万|-69.65%|3.94万|#|2025-07-28|20.22万|446.21%|12.76万|#|2025-07-25|3.70万|-81.57%|2.11万|Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801092628a6cca168&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801092628a6cca168&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","BRNS"],"gpt_icon":0},{"id":"2555602908","title":"Barinthus Biotherapeutics Plc盘中异动 股价大跌5.23%报1.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555602908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555602908?lang=zh_cn&edition=full","pubTime":"2025-07-31 03:29","pubTimestamp":1753903779,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日03时29分，Barinthus Biotherapeutics Plc股票出现波动，股价快速跳水5.23%。截至发稿，该股报1.45美元/股，成交量1.533万股，换手率0.04%，振幅6.21%。Barinthus Biotherapeutics Plc股票所在的生物技术行业中，整体跌幅为0.14%。Barinthus Biotherapeutics Plc公司简介：Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731032939a6ca245c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731032939a6ca245c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","BRNS"],"gpt_icon":0},{"id":"2555052314","title":"Barinthus Biotherapeutics Plc盘中异动 早盘股价大涨6.45%报1.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555052314","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555052314?lang=zh_cn&edition=full","pubTime":"2025-07-29 21:41","pubTimestamp":1753796474,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日21时41分，Barinthus Biotherapeutics Plc股票出现异动，股价快速上涨6.45%。截至发稿，该股报1.65美元/股，成交量3029股，换手率0.01%，振幅1.04%。Barinthus Biotherapeutics Plc股票所在的生物技术行业中，整体涨幅为0.22%。Barinthus Biotherapeutics Plc公司简介：Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729214114a469cb81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729214114a469cb81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BRNS","BK4139"],"gpt_icon":0},{"id":"2554772154","title":"Barinthus Biotherapeutics Plc盘中异动 早盘快速下跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554772154","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554772154?lang=zh_cn&edition=full","pubTime":"2025-07-28 21:30","pubTimestamp":1753709434,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日21时30分，Barinthus Biotherapeutics Plc股票出现波动，股价急速下跌5.31%。Barinthus Biotherapeutics Plc股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Celcuity Inc.、Aim Immunotech Inc.、Cervomed Inc.涨幅较大，Aim Immunotech Inc.、Cervomed Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为212.49%、79.70%、79.66%，振幅较大的相关个股有Celcuity Inc.、Aim Immunotech Inc.、Mersana Therapeutics, Inc.，振幅分别为23.86%、15.47%、8.31%。Barinthus Biotherapeutics Plc公司简介：Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728213034a467d8ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728213034a467d8ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BRNS","BK4539"],"gpt_icon":0},{"id":"2554718631","title":"Barinthus Biotherapeutics Plc7月25日成交额为3.70万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554718631","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554718631?lang=zh_cn&edition=full","pubTime":"2025-07-26 09:27","pubTimestamp":1753493264,"startTime":"0","endTime":"0","summary":"美东时间2025年7月25日，Barinthus Biotherapeutics Plc成交额为3.70万美元，成交额较昨日减少81.57%，当日成交量为2.11万股。Barinthus Biotherapeutics Plc于2025年7月25日涨2.58%，报1.79美元，该股过去5个交易日涨19.33%，年初至今涨47.93%，过去60日涨79.0%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-25|3.70万|-81.57%|2.11万|#|2025-07-24|20.09万|24.01%|11.27万|#|2025-07-23|16.20万|-51.49%|8.39万|#|2025-07-22|33.39万|-95.66%|18.25万|#|2025-07-21|769.99万|1168.34%|340.11万|Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726092752a4641920&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726092752a4641920&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","BRNS"],"gpt_icon":0},{"id":"2553224707","title":"Barinthus Biotherapeutics Plc7月23日成交额为16.20万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553224707","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553224707?lang=zh_cn&edition=full","pubTime":"2025-07-24 09:26","pubTimestamp":1753320365,"startTime":"0","endTime":"0","summary":"美东时间2025年7月23日，Barinthus Biotherapeutics Plc成交额为16.20万美元，成交额较昨日减少51.49%，当日成交量为8.39万股。Barinthus Biotherapeutics Plc于2025年7月23日涨5.52%，报1.91美元，该股过去5个交易日涨34.51%，年初至今涨57.85%，过去60日涨132.08%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-23|16.20万|-51.49%|8.39万|#|2025-07-22|33.39万|-95.66%|18.25万|#|2025-07-21|769.99万|1168.34%|340.11万|#|2025-07-18|60.71万|-82.05%|40.35万|#|2025-07-17|338.27万|-97.79%|206.38万|Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724092607a46015df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724092607a46015df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BRNS","BK4539"],"gpt_icon":0},{"id":"2553679712","title":"Barinthus Biotherapeutics Plc7月22日成交额为33.39万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553679712","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553679712?lang=zh_cn&edition=full","pubTime":"2025-07-23 09:25","pubTimestamp":1753233927,"startTime":"0","endTime":"0","summary":"美东时间2025年7月22日，Barinthus Biotherapeutics Plc成交额为33.39万美元，成交额较昨日减少95.66%，当日成交量为18.25万股。Barinthus Biotherapeutics Plc于2025年7月22日跌8.12%，报1.81美元，该股过去5个交易日涨77.45%，年初至今涨49.59%，过去60日涨121.81%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-22|33.39万|-95.66%|18.25万|#|2025-07-21|769.99万|1168.34%|340.11万|#|2025-07-18|60.71万|-82.05%|40.35万|#|2025-07-17|338.27万|-97.79%|206.38万|#|2025-07-16|1.53亿|1366360.83%|6986.97万|Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723092529a6bc04a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723092529a6bc04a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BRNS","BK4139"],"gpt_icon":0},{"id":"2552725458","title":"Barinthus Biotherapeutics Plc7月17日成交额为338.27万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552725458","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552725458?lang=zh_cn&edition=full","pubTime":"2025-07-18 09:24","pubTimestamp":1752801867,"startTime":"0","endTime":"0","summary":"美东时间2025年7月17日，Barinthus Biotherapeutics Plc成交额为338.27万美元，成交额较昨日减少97.79%，当日成交量为206.38万股。Barinthus Biotherapeutics Plc于2025年7月17日涨7.75%，报1.53美元，该股过去5个交易日涨44.34%，年初至今涨26.45%，过去60日涨115.49%。该公司作为一个部门运营，即免疫疗法和疫苗的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718092434a4522697&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718092434a4522697&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","BRNS"],"gpt_icon":0},{"id":"2551659129","title":"Barinthus Biotherapeutics Plc盘中异动 快速拉升5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551659129","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551659129?lang=zh_cn&edition=full","pubTime":"2025-07-16 22:36","pubTimestamp":1752676590,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日22时36分，Barinthus Biotherapeutics Plc股票出现异动，股价快速拉升5.88%。Barinthus Biotherapeutics Plc股票所在的生物技术行业中，整体涨幅为1.24%。Barinthus Biotherapeutics Plc公司简介：Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507162236309544f9a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507162236309544f9a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BRNS","BK4139","BK4539"],"gpt_icon":0},{"id":"2550295147","title":"Barinthus Biotherapeutics Plc盘中异动 股价大跌5.09%报1.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550295147","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550295147?lang=zh_cn&edition=full","pubTime":"2025-07-11 21:56","pubTimestamp":1752242163,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日21时56分，Barinthus Biotherapeutics Plc股票出现异动，股价急速跳水5.09%。截至发稿，该股报1.01美元/股，成交量522股，换手率0.00%，振幅0.00%。Barinthus Biotherapeutics Plc股票所在的生物技术行业中，整体跌幅为0.81%。Barinthus Biotherapeutics Plc公司简介：Barinthus Biotherapeutics PLC 是一家临床阶段的生物制药公司，开发新型 T 细胞免疫疗法，指导免疫系统克服慢性传染病、自身免疫和癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711215603a44507c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711215603a44507c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","BRNS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.barinthusbio.com","stockEarnings":[{"period":"1week","weight":-0.1078},{"period":"1month","weight":-0.1667},{"period":"3month","weight":-0.2088},{"period":"6month","weight":-0.4927},{"period":"1year","weight":-0.3922},{"period":"ytd","weight":-0.1016}],"compareEarnings":[{"period":"1week","weight":-0.0128},{"period":"1month","weight":-0.0125},{"period":"3month","weight":0.0146},{"period":"6month","weight":0.0595},{"period":"1year","weight":0.1181},{"period":"ytd","weight":-0.0002}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Barinthus Biotherapeutics plc于2016年1月根据英格兰和威尔士的法律注册成立。该公司是一家临床阶段的生物制药公司，致力于发现和开发新型T细胞免疫治疗候选药物，旨在引导免疫系统克服慢性传染病、自身免疫和癌症。该公司拥有广泛的临床和临床前阶段治疗和预防项目。该公司目前的治疗方案包括用于治疗慢性乙型肝炎感染的VTP-300，用于治疗人乳头状瘤病毒感染的VTP-200，用于治疗前列腺癌的VTP-850，用于治疗非小细胞肺癌的VTP-600，用于治疗乳糜泻的VTP-1000，以及用于治疗HPV相关癌症的VTP-1100。后两个程序旨在利用SNAPvaxTM平台。该公司目前的预防项目包括用于预防带状疱疹或带状疱疹的VTP-400，以及用于预防中东呼吸综合征或MERS的VTP-500。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.054418},{"month":2,"riseRate":0.2,"avgChangeRate":-0.088464},{"month":3,"riseRate":0,"avgChangeRate":-0.162289},{"month":4,"riseRate":0.75,"avgChangeRate":0.019565},{"month":5,"riseRate":0.4,"avgChangeRate":-0.038691},{"month":6,"riseRate":0.4,"avgChangeRate":-0.079301},{"month":7,"riseRate":0.8,"avgChangeRate":0.145921},{"month":8,"riseRate":0.2,"avgChangeRate":-0.115362},{"month":9,"riseRate":0.6,"avgChangeRate":0.076316},{"month":10,"riseRate":0.6,"avgChangeRate":0.081459},{"month":11,"riseRate":0,"avgChangeRate":-0.272926},{"month":12,"riseRate":0.6,"avgChangeRate":0.072478}],"exchange":"NASDAQ","name":"BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON","nameEN":"BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON(BRNS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON(BRNS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON,BRNS,BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON股票,BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON股票老虎,BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON股票老虎国际,BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON行情,BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON股票行情,BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON股价,BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON股市,BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON股票价格,BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON股票交易,BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON股票购买,BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON(BRNS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON(BRNS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}